Cogent Biosciences, Inc. (COGT)

37.66 -0.68 (-1.77%) USD  |  NASDAQ  |  Feb 20, 14:10
More

Cogent Biosciences EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. --
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade